Iterative Health

Iterative Health, founded in 2018 and headquartered in Cambridge, Massachusetts, is a private company building an AI-powered platform and site network to transform clinical trial execution in GI and hepatology. By partnering with major provider networks like GI Alliance and One GI, it centralizes access to a large, community-based patient population and provides sites with operational support and technology to improve performance. The company's core value proposition is accelerating trial timelines for sponsors through faster site activation, predictable patient enrollment, and reduced risk, thereby addressing critical inefficiencies in the clinical development process.

AI and machine learning platform for clinical trial acceleration, including patient identification, site performance analytics, and operational workflow tools for GI and hepatology trials.

Iterative Health competes with large, full-service Contract Research Organizations (CROs) and other decentralized clinical trial (DCT) technology providers. Its differentiation lies in its deep, exclusive focus on GI/hepatology, its owned and managed network of community-based sites, and its integrated AI platform tailored to this specialty.